ARCHIVES

First-Line Tarceva Nearly Doubles PFS in EGFR-Activated Tumors

This article is from The Cancer Letter archive.

Vol. 34 No. 6 | June 24, 2011

Download PDF Visit The Full Archive

Related Articles

Management Survey Finds Problems At ACS, Advises Change

July 3, 1992

NCI program announcement available, contract awards listed.

November 14, 2003

Excerpts From A Confidential Report Detailing the I-ELCAP Study’s Design Flaws and Lack of Consent

April 29, 2011

Also MSKCC picks David Kissane to succeed Jimmie Holland as chairman of psychiatry and behavioral sciences.

October 24, 2003

In Brief: Paul Sugarbaker to Head New DC Cancer Center; Michael Shimkin Dies; Tel Aviv Conference “Safe”

January 27, 1989

Palmetto Establishes Coverage For Thyroid Genomic Test

January 27, 2012